Effectiveness of an Innovative Nursing Approach Through a Smartphone Application in Promoting Medication Adherence Among Patients with Schizophrenia
Abstract
Objective: This study aimed to investigate the effects of an innovative nursing approach using a smartphone application, namely “Kin Ya Kan Na” or “Let’s take Medications,” on medication adherence behaviors among patients with schizophrenia.
Material and Methods: Purposive sampling was used to recruit the participants (n=84). They were randomly assigned into either an experimental (n=42) or control (n=42) group. The experimental group installed this application on their smartphones and used it for one month, along with usual nursing care while the control group received only the usual nursing care. Data were collected before and after the intervention using: 1) a demographic data form, 2) the Medication Adherence Scale in Thai (MAST), and 3) a satisfaction towards application usability’ scale. These two scales yielded Cronbach alpha coefficients of 0.94 and 0.86, respectively. Descriptive statistics and analysis of covariance (ANCOVA) were employed for data analyses.
Results: The post-intervention analysis showed that the medication adherence behaviors between the two groups were significantly different (F1,81=65.225, p-value<0.001), with higher mean scores for medication adherence behaviors in theexperimental group. The application users reported that they were highly satisfied with the application (M=4.51, S.D.=0.38).
Conclusion: The study found that use of this innovative nursing approach significantly improved medication adherence behaviors among these patients. Therefore, nurses and related healthcare providers could apply this approach to promote medication adherence behaviors in patients with mental illness, particularly schizophrenia.
Keywords
Full Text:
PDFReferences
Wuthironarith V. Promoting medication adherence in persons with schizophrenia in community. JPNMH 2017;3:1-12.
Suwannapong K, Klungrit S. Improving medication adherence in older persons with chronic illness. RTNNMD J 2019; 46:717-31.
Velligan DI, Weiden PJ, Sajatovic M, Scott J, Carpenter D, Ross R, et al. Expert consensus panel on adherence problems in serious and persistent mental illness. The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness. J Clin Psychiatry 2009;70:41-6. doi: 10.1097/01.pra.0000367776. 96012.ca
Gray R, Bressington D, Ivanecka A, Hardy S, Jones M, Schulz M, et al. Is adherence therapy an effective adjunct treatment for patients with schizophrenia spectrum disorders? a systematic review and meta-analysis. BMC Psychiatry 2016;16:90. doi: 10.1186%2Fs12888-016-0801-1.
Department of Mental Health Policy Annual 2020 [Internet]. Nonthaburi: Department of Mental Health; 2020 [cited 2022 Nov 9]. Available from: https://dmh.go.th/intranet/p2554/policy/
Chien WT, Mui JH, Cheung EF, Gray R. Effects of motivational interviewing-based adherence therapy for schizophrenia spectrum disorders: a randomized controlled trial. Trials 2015;16: 270. doi: 10.1186/s13063-015-0785-z.
Murasugi K, Tsukahara T, Washizuka S. The development and trial of a medication discontinuation program in the department of forensic psychiatry. Ann Gen Psychiatry 2015;14:11. doi: 10.1186/s12991-015-0049-z.
Prevention of mental disorders: Effective intervention and policy options. [homepage on the Internet]. Nonthaburi: Department of Mental Health; 2020 [cited 2022 Nov 9]. Available from: https://dmh.go.th/formrptdmh/
Velligan DI, Sajatovic M, Hatch A, Kramata P, Docherty JP. Why do psychiatric patients stop antipsychotic medication? A systematic review of reasons for nonadherence to medication in patients with serious mental illness. Patient Prefer Adherence 2017;11:449-68. doi: 10.2147/ppa.s124658.
Barkhof E, Meijer CJ, de Sonneville LM, Linszen DH, de Haan L. Interventions to improve adherence to antipsychotic medication in patients with schizophrenia--a review of the past decade. Eur Psychiatry 2012;27:9-18. doi: 10.1016/j.eurpsy.2011.02.005.
Sudjai P, Hengudomsub P, Chaimongkol N. Feasibility of the Motivational Interview based Adherence Therapy (MIAT) with family support program to promote medication adherence for persons with schizophrenia. TPHSJ 2020;16:1-12.
Al-Arkee S, Mason J, Lane DA, Fabritz L, Chua W, Haque MS, et al. Mobile apps to improve medication adherence in cardiovascular disease: systematic review and meta-analysis. J Med Internet Res 2021;23:e24190. doi: 10.2196%2F24190.
Lapponampai W, Pamonsinlapatham P. Application program for Anti-HIV drug self-management on android smart phone. TJST 2018;27:738-50.
Pacharapakornsin P, Srichai A, Wijit W, Singkaeo D. The effects of a telephone intervention program on medical adherence among people with mental health problems. JFONUBUU 2021;29:95-104.
Schunk DH, Zimmerman BJ. Social origins of self-regulatory competence. Educational Psychologist 1997;32:195-208. doi: 10.1207/s15326985ep3204_1.
Morelli SA, Lee IA, Arnn ME, Zaki J. Emotional and instrumental support provision interact to predict well-being. Emotion 2015;15:484-93. doi: 10.1037/emo0000084.
Pérez-Jover V, Sala-González M, Guilabert M, Mira JJ. Mobile apps for increasing treatment adherence: systematic review. J Med Internet Res 2019;21:e12505. doi: 10.2196%2F12505.
Suphachamroon A, Lerkiatbundit S, Saengcharoen V. Validity and reliability of the medication adherence scale in thai (mast): testing in diabetes patients. Thai J Pharm Prac 2018;10:607-19.
Arafat Y, Mohamed Ibrahim MI, Awaisu A, Colagiuri S, Owusu Y, Morusky DE, et al. Using the transtheoretical model’s stages of change to predict medication adherence in patients with type 2 diabetes mellitus in a primary health care setting. Daru 2019;27:91-9. doi: 10.1007/s40199-019-00246-7.
Chen P, Shen Y, He C, Sun X. Effectiveness of a transtheoretical model-based intervention to improve blood pressure control of hypertensive patients in China: a clustered randomized controlled trial. Front Public Health 2022;9:e760421. doi: 10.3389/fpubh.2021.760421.
Kassianos AP, Georgiou G, Papaconstantinou EP, Detzortzi A, Horne R. Smartphone applications for educating and helping non-motivating patients adhere to medication that treats mental health conditions: aims and functioning. Front Psychol 2017;8: e1769. doi: 10.3389/fpsyg.2017.01769.
Bianco CL, Myers AL, Smagula S, Fortuna KL. Can smartphone apps assist people with serious mental illness in taking medications as prescribed? Sleep Med Clin 2021;16:213-22. doi: 10.1016/j.jsmc.2020.10.010.
Stawarz K, Cox A, Blandford A. Don’t forget your pill! designing effective medication reminder apps that support users’ daily routines. In: Conference on human factors in computing systems; April, 2014; Toronto:Canada. doi: 10.1145/2556288.2557079.
Fallah M, Yasini M. A Medication Reminder mobile app: does it work for different age ranges. Stud health technol inform 2017;235:68-72.
Ameta D, Mudaliar K, Patel P. Medication reminder and healthcare–an android application. IJMPICT 2015;6:39-48. doi: 10.5121/ijmpict.2015.6204.
Ronglong S, Sookplang C, Arpnikanondt C, Vanijja V. Design of a medication reminder and feedback system for thai elders. In: a conference of World Engineering, Science and Technology Congress; June 14, 2012; Bangkok:Thailand. doi: 10.1109/ICCISci.2012.6297210.
Backes C, Moyano C, Rimaud C, Bienvenu C, Schneider MP. Digital medication adherence support: could healthcare providers recommend mobile health apps? Front Med Technol 2021; 17:e616242. doi: 10.3389/fmedt.2020.616242.
Mohammadi TS, Negahban BT, Heidari S. Effectiveness of smartphone-based medication reminder application on medication adherence of patients with essential hypertension: A clinical trial study. J Nurs Midwifery Sci 2020;7:219-25. doi: 10.4103/JNMS.JNMS_16_20.
Osahon TP, Mote AL, Ntaji IV. Assessment of the impact of medPlan®, a medication reminder mobile application, in glaucoma patients in Benin City, Nigeria. Trop J Pharm Res 2020;19:2677-82. doi: 10.4314/tjpr.v19i12.28.
Whitehead AL, Julious SA, Cooper CL, Campbell MJ. Estimating the sample size for a pilot randomised trial to minimise the overall trial sample size for the external pilot and main trial for a continuous outcome variable. Stat Methods Med Res 2016; 25:1057-73. doi: 10.1177/0962280215588241.
Refbacks
- There are currently no refbacks.
![Creative Commons License](http://i.creativecommons.org/l/by-nc-nd/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.